Parallax Volatility Advisers’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,141
| Closed | -$17.6K | – | 1096 |
|
|
2024
Q1 | $17.6K | Sell |
12,141
-12,859
| -51% | -$18.6K | ﹤0.01% | 501 |
|
|
2023
Q4 | $1.88K | Hold |
25,000
| – | – | ﹤0.01% | 594 |
|
|
2023
Q3 | $3.75K | Sell |
25,000
-458,535
| -95% | -$68.8K | ﹤0.01% | 625 |
|
|
2023
Q2 | $43.5K | Sell |
483,535
-377,003
| -44% | -$33.9K | ﹤0.01% | 558 |
|
|
2023
Q1 | $47.3K | Sell |
860,538
-14,590
| -2% | -$802 | ﹤0.01% | 589 |
|
|
2022
Q4 | $39.9K | Sell |
875,128
-283,977
| -24% | -$12.9K | ﹤0.01% | 628 |
|
|
2022
Q3 | $87K | Buy |
1,159,105
+122,087
| +12% | +$9.16K | ﹤0.01% | 703 |
|
|
2022
Q2 | $156K | Buy |
1,037,018
+273,323
| +36% | +$41.1K | ﹤0.01% | 675 |
|
|
2022
Q1 | $241K | Buy |
763,695
+372,006
| +95% | +$117K | ﹤0.01% | 621 |
|
|
2021
Q4 | $200K | Buy |
391,689
+228,940
| +141% | +$117K | ﹤0.01% | 496 |
|
|
2021
Q3 | $95K | Buy |
+162,749
| New | +$95K | ﹤0.01% | 554 |
|